Emerging Non-opiod Pharmaceuticals for Pain Management
Emerging narcotic-free therapies
27-May-2020
Global
Technology Research
D97A-01-00-00-00
HC03297-GL-TR_24422
The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain. Key application areas explored in the research include neuropathic pain, migrane, post-surgical pain, cancer pain, chronic pain and migraine. The research encompasses technological advances across Nav1.7 inhibitors, Calcitonin Gene-related peptide inhibitors, Platelet rich plasma therapy, Ditans, Hydrogel therapy, and stem cell therapy among several others.The research also provides competitive intelligence across emerging innovators in this space, while provide insights across the patent landscape for non-narcotic pain therapy.
1.1 Key Findings
1.2 Analysis Framework: Frost & Sullivan’s Core Value
1.3 Research Methodology
2.1 Global Non-opioid Market
2.2 NSAIDs Continue to be Important for Pain Treatment
2.3 Types of Non-opioid Pharmaceuticals
2.4 Categories of Non-opioids in Development for Pain Management
2.4.1 Recently Approved Monoclonal Antibodies for Pain Management
2.5 Emerging Non-opioid Analgesics
2.6 Advanced Academic Researches in Pain Therapy
2.6 Advanced Academic Researches in Pain Therapy (continued)
3.1 Innovation Radar of Emerging Technologies
3.2 Summary of the Scoring Methodology
3.2.1 QBioMed
3.2.1 QBioMed (continued)
3.2.2 Centrexion Therapeutics
3.2.2 Centrexion Therapeutics (continued)
3.2.3 Concentric Analgesics
3.2.3 Concentric Analgesics (continued)
3.2.4 Xenon Pharmaceuticals
3.2.4 Xenon Pharmaceuticals (continued)
3.2.5 KinetaBio
3.2.5 KinetaBio (continued)
3.2.6 Navega Therapeutics
3.2.6 Navega Therapeutics (continued)
3.2.7 Tetra Biopharma
3.2.7 Tetra Biopharma (continued)
3.2.8 Vapogenix
3.2.8 Vapogenix (continued)
4.1 Pain Therapy Innovations Roadmap
4.2 Growth Opportunity 1: R&D Investment
4.3 Growth Opportunity 2: Technology Convergence
4.4 Conclusion
5.1 IP Overview in Non-opioid Pharmaceuticals
5.2 Leading Pharmaceutical Patent Holders
5.3 Patent Scenario
5.3Patent Scenario
6.1 List of Non-opioids in the Market
6.2 Key Industry Contacts
6.2 Key Industry Contacts (continued)
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
19 Nov 2026 | Global | Technology Research
Programmable Vaccines: AI-Designed Antigens and Next-Generation Rapid Platforms
Traditional vaccine development is an empirical, time-consuming process that often leads to a high failure rate. With the proven clinical success of RNA vaccines, there has been a focus on accelerating the development of vaccines to address the growing incidence of infectious diseases and emerging p...
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.